期刊文献+

结核性脑膜炎临床分离株的耐药性和基因型相关性分析

Analysis of the relativity between the drug resistance and genotype of clinical strains isolated from tuberculous meningitis
下载PDF
导出
摘要 目的 了解结核性脑膜炎(tuberculous meningitis,TBM)的致病菌在耐药性和基因型方面的相关性.方法 从500例疑似TBM患者脑脊液标本中经MGIT(Mycobacteria growth indicator tube)960培养仪分离培养出25株结核分枝杆菌(Mycobacterium tuberculosis,Mtb),对这25株Mtb分别进行间隔区寡核苷酸分型(Spoligotyping)法基因分型、14种抗结核药物的药物敏感性试验、10个耐药基因测序.结果 20株为北京基因型,占80.0%(20/25);耐多药结核性脑膜炎(MDR TBM)有3株(3/25),都属于北京基因型;测序结果显示inhA、embB、gyrB、eis 基因未发生突变,katG、rpoB、gyrA、rrs-KAN、rpsL、gidB基因发生突变.结论 北京基因型在耐药TBM中所占比例高,尤其是MDR-TBM.耐药TBM临床分离株与相关耐药基因突变有关系. Objective To study the relativity between the drug resistance and genotype of clinical strains isolated from tuberculous meningitis (TBM).Methods M.tuberculosis was cultured and isolated in cerebrospinal fluids (CSF) from 25 cases diagnosed with TBM in Xijing Hospital.These isolates were performed the susceptibility testing of 14 antituberculosis drugs,the sequencing of 10 drug-resistant genes and strain typing by Spoligotyping.Results Of 2 5 M.tuberculosis isolates,20 (80.0 %) clinical isolates were identified as Beijing genotype by Spoligotyping; 3 (3/25) strains were multidrug-resistant (MDR) and belonged to Beijing genotype,in which katG,rpoB,gyrA,rrs-KAN,rpsL,gidB genes were found the mutations,but inhA,embB,gyrB,eis genes had not mutation by the DNA sequencing.Conclusion Beijing genotype strains may act as the main epidemic strain of TBM,especially MDR TBM.
出处 《中国防痨杂志》 CAS 2014年第6期411-417,共7页 Chinese Journal of Antituberculosis
关键词 结核 脑膜 抗药性 细菌 分枝杆菌 结核 基因型 Tuberculosis, meningeal Mycobacterium tuberculosis Drug resistance, bacterial Genotype
  • 相关文献

参考文献22

  • 1Garg RK,Jain A, Malhotra HS,et al. Drug-resistant tuberculous meningitis. Expert Rev Anti Infect Ther,2013,11(6):605-621.
  • 2Kontos F, Maniati M, Costopoulos C,et al. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods, 2004,56(2):291-294.
  • 3Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.Tuber Lung Dis,1998,79(1):3-29.
  • 4刘佳文,吕红艳,等.16SrRNA基因序列在分枝杆菌分类鉴定的研究进展[J].国外医学(临床生物化学与检验学分册),2001,22(5):265-266. 被引量:11
  • 5Marais S, Thwaites G, Schoeman JF,et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010,10(11): 803-812.
  • 6中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育出版社,2006,46-51.
  • 7Parish T, Stoker NG.Mycobacteria protocols.Totowa:Humana Press, 1998.
  • 8World Health Organization. Policy guidance on drug-susceptibility testing(DOS) of second-line antituberculosis drugs. WHO/HTM/TB/2008.392. Geneva:World Health Organization,2008.
  • 9Pang Y, Zhou Y, Zhao B, et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One, 2012,7(3):e32976.
  • 10Duong DA, Nguyen TH, Nguyen TN,et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluroquinolone resistance in Vietnam. Antimicrob Agents Chemother,2009,53(11):4835-4839.

二级参考文献36

  • 1Rogall T, Flohr T, Bottger E. Differentiation of mycobacterium species by direct sequencing of amplified DNA[J]. J Gen Microbiol, 1990,136:1916~1920.
  • 2Gabrielle ME Vliet VD, Schukkink RAF, et al. Nucleic acid squence-based amplification(NASBA) for the identification of mycobacterium [J]. J Gen Microbiol, 1993,139:2423~2429.
  • 3Kipschner P, Springer B, Uvogel, et al. Genotypic identification of mycobacteria by nucleic acid sequence determination:report of a 2-year experience in a clinical laboratory [J]. J Clin Mycobiol,1993,31:2882~2889.
  • 4Patel JB, Leonard DGB, Pan X, et al. Sequence-based identification of mycobacterium by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory[J]. J Clin Mycobiol,2000,38: 246~251.
  • 5Hughes MS, Skuce RA, Beck LA, et al. Identification of mycobacteria from animals by restriction enzyme analysis and direct DNA cycle sequencing of polymerase chain reaction amplified 16S rRNA gene sequence[J]. J Clin Microbiol, 1993,31: 3216~3222.
  • 6Hughes MS, James G, Ball N. Identification by 16S rRNA gene analyses of a potential novel mycobacterial species as an etiological agent of canine leproid granuloma syndrome [J]. J Clin Microbiol, 2000,38: 953~959.
  • 7Vaneechoutte M, H De Beehouwer, Claeys G, et al. Identification of mycobacterium species by using amplified ribosomal DNA restriction analysis[J]. J Clin Microbiol,1993,31:2061~2065.
  • 8Avaniss Aghajini E, Jones K, Holtzman A, et al. Molecular technique for rapid identification of mycobacteria[J]. J Clin Microbiol, 1996,34: 98~ 102.
  • 9Hernandez SM, Morolock GP, Butler WR, et al. Identification of mycobacterium species by PCR-restriction fragment length polymorphism analyses using fluorescence cap illary electrophoresis[J]. J Clin Microbiol, 1999,37:3688~3692.
  • 10Beenhouwer HD, Zhong L, Rijk PD, et al. Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization[J]. J Clin Microbiol, 1995,33: 2994~ 2998.

共引文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部